SEC Form D · Amendment · filed February 21, 2017
Faraday Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Brian Blackman · Seattle, WAExecStephen Hill · Seattle, WAExec · DirectorThomas King · Seattle, WADirectorSteven Gillis · Seattle, WAExec · Director · PromoterMark Roth · Seattle, WAExec · Director · PromoterSimon Tulloch · Seattle, WAExecCandace J. Woods · Newark, NJExec · Director · PromoterAdam G. Yader · Monterey, CAExecParker Spann · St. Louis, MOExecJason G. Klarreich · New York, NYDirectorDavid Richardson · George Town, Cayman IslandsExec · DirectorAndrew Hersant · George Town, Cayman IslandsExec · Director · PromoterPaulina Hill · Seattle, WADirectorJanet Kraus · WALTHAM, MADirectorDerek Ohly · WALTHAM, MAExecAndreas Guldin · WALTHAM, MAExecElizabeth Campbell · Long Island City, NYExec · Director · PromoterJoseph Luceri · Long Island City, NYExec · Director · PromoterScott Perricelli · Long Island City, NYExec · DirectorPaulina Hill · Seattle, WADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗